Talaris Therapeutics (TALS) director Agarwala received 20,500 Stock Option (Right to Buy)
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Sandip Agarwala (director at Talaris Therapeutics Inc., TALS) reported that they received 20,500 Stock Option (Right to Buy) on Jun 13, 2023.
- Reporting person
- Agarwala Sandip
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jun 13, 2023 | Grant or award (A) | Stock Option (Right to Buy)On 20,500 Common Stock1 | +20,500 | - | - | 20,500 direct |
Holdings before and after
- Stock Option (Right to Buy): 0 to 20,500 direct
Footnotes from the filing
- 1. The shares underlying this option shall vest as follows: the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Agarwala report in this TALS Form 4?
Sandip Agarwala (director at Talaris Therapeutics Inc., TALS) reported that they received 20,500 Stock Option (Right to Buy) on Jun 13, 2023.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for TALS
Earlier insider filings at TALS
- Jun 9, 2023SEC Form 4 filed by Ildstad Suzanne
- Jun 7, 2023SEC Form 4 filed by Ildstad Suzanne
- Jun 5, 2023SEC Form 4 filed by Ildstad Suzanne
- Apr 25, 2023SEC Form 4 filed by Ildstad Suzanne
- Apr 21, 2023SEC Form 4 filed by Ildstad Suzanne
Quantisnow market dataNASDAQ
TALS
Talaris Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2021
Get push alerts for TALS
Full TALS profile on Quantisnow Follow TALS and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time